Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Author： Ogura Michinori   Hatake Kiyohiko   Tobinai Kensei   Uchida Toshiki   Suzuki Tatsuya   Terui Yasuhito   Yokoyama Masahiro   Maruyama Dai   Mori Masakazu   Jewell Roxanne C.   Katsura Koichi   Hotta Tomomitsu  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.5, 2013-05, pp. : 466-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients

By Ahmed Tamer   Hayslip John   Leggas Markos  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1369-1374

Springer Publishing Company

Access to resources Recommend Favorite

Intracerebral Hodgkin's Lymphoma in a Patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Literature Review

By Almhanna Khaldoun   Wongchaowart Nicholas   Sweetenham John  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma

By Appleby Niamh   Dillon Anna   Arrigan Martin   Fennell Jerome   Crowley Brendan   Hayden Patrick J.   Enright Helen  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1181-1183

Informa Healthcare

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options

By Wierda William G.   Keating Michael J.   O'Brien Susan  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 163-178

Adis International

Access to resources Recommend Favorite